Venous thromboembolism in obstetrics and gynecology.
The diagnosis of venous thromboembolism can present a clinical challenge. Using D-dimer testing and spiral or helical computed tomography scans has simplified the diagnosis of venous thromboembolism. In addition, the use of low molecular weight heparin has become widely accepted in the prevention and treatment of venous thromboembolism. However, further studies are needed to determine optimal prevention and treatment strategies, particularly in the obstetric population.
Krivak
Thomas C
TC
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Magee-Womens Hospital, 300 Halket Street, Pittsburgh, Pennsylvania 15213, USA. tkrivak@mail.magee.edu
Zorn
Kristin K
KK
D000465:Algorithms; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D019851:Thrombophilia / Q000453:epidemiology; D016306:Vena Cava Filters; D020246:Venous Thrombosis / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D014692:Ventilation-Perfusion Ratio
D000925:Anticoagulants; D005338:Fibrin Fibrinogen Degradation Products; D006495:Heparin, Low-Molecular-Weight; C036309:fibrin fragment D; D006493:Heparin